Cite
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma.
MLA
Negro, Roberto W.Dal, et al. “Fluticasone Furoate/Vilanterol 92/22 Μg Once-a-Day vs Beclomethasone Dipropionate/ Formoterol 100/6 Μg b.i.d.: A 12-Week Cost Analysis in Mild-to-Moderate Asthma.” Multidisciplinary Respiratory Medicine, vol. 11, June 2016, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s40248-016-0055-2.
APA
Negro, R. W. D., Distante, C., Bonadiman, L., Turco, P., & Iannazzo, S. (2016). Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma. Multidisciplinary Respiratory Medicine, 11, 1–7. https://doi.org/10.1186/s40248-016-0055-2
Chicago
Negro, Roberto W. Dal, Chiara Distante, Luca Bonadiman, Paola Turco, and Sergio Iannazzo. 2016. “Fluticasone Furoate/Vilanterol 92/22 Μg Once-a-Day vs Beclomethasone Dipropionate/ Formoterol 100/6 Μg b.i.d.: A 12-Week Cost Analysis in Mild-to-Moderate Asthma.” Multidisciplinary Respiratory Medicine 11 (June): 1–7. doi:10.1186/s40248-016-0055-2.